Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $452000.0.

  • International Stem Cell's Accumulated Expenses fell 484.21% to $452000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $452000.0, marking a year-over-year decrease of 484.21%. This contributed to the annual value of $527000.0 for FY2024, which is 865.98% up from last year.
  • As of Q3 2025, International Stem Cell's Accumulated Expenses stood at $452000.0, which was down 484.21% from $651000.0 recorded in Q2 2025.
  • International Stem Cell's 5-year Accumulated Expenses high stood at $651000.0 for Q2 2025, and its period low was $284000.0 during Q3 2021.
  • In the last 5 years, International Stem Cell's Accumulated Expenses had a median value of $508000.0 in 2022 and averaged $510578.9.
  • As far as peak fluctuations go, International Stem Cell's Accumulated Expenses plummeted by 2406.42% in 2021, and later soared by 6725.35% in 2022.
  • Over the past 5 years, International Stem Cell's Accumulated Expenses (Quarter) stood at $404000.0 in 2021, then grew by 25.74% to $508000.0 in 2022, then decreased by 4.53% to $485000.0 in 2023, then rose by 8.66% to $527000.0 in 2024, then dropped by 14.23% to $452000.0 in 2025.
  • Its Accumulated Expenses was $452000.0 in Q3 2025, compared to $651000.0 in Q2 2025 and $608000.0 in Q1 2025.